Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Becton Dickinson And Company (GB:0R19)
LSE:0R19
Becton Dickinson (0R19) Share Price & Analysis
0 Followers
0R19 Stock Chart & Stats
Day’s Range$230.5 - $236.63
52-Week Range― - ―
Previous Close$234.23
Volume1.40K
Average Volume (3M)N/A
Market Cap
$67.71B
Enterprise Value$82.64B
Total Cash (Recent Filing)$1.18B
Total Debt (Recent Filing)$16.11B
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 02, 2024EPS Estimate
$2.97Last Dividend Ex-Date
Mar 07, 2024Dividend Yield1.59%
Share Statistics
EPS (TTM)N/A
Shares Outstanding288,902,232
10 Day Avg. Volume16,419
30 Day Avg. Volume5,875
Standard Deviation0.07
R-Squared0.13
Alpha0.00667
Financial Highlights & Ratios
Price to Book (P/B)375.30
Price to Sales (P/S)3.92
Price to Cash Flow (P/CF)19.80
P/FCF Ratio20.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.35
Enterprise Value/Gross Profit10.11
Enterprise Value/Ebitda18.17
Forecast
1Y Price Target
$288.71Price Target Upside24.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Becton Dickinson News
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceEPS of $2.68 topped the $2.40 estimate, helped by a one-time tax item but also by good execution on margin goals.
Financial ForecastAnalyst expects operational improvement through the year.
Revenue GuidanceBDX Favorably Revised Its Guidance: The company now projects F2024 reported revenue of $20.2B-$20.4B compared to $20.1B-$20.3B previously.
Bears Say
Financial PerformanceSignificant headwinds including foreign exchange and outsized inflation impacted margins.
RevenueF1Q revenue of $4.71B fell modestly short of the $4.73B consensus, reflecting 2.4% organic growth.
Sector PerformanceLife Sciences sales retreated 2.5% CC from the prior year, hurt by the comparison to strong respiratory testing revenue in F1Q'23.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.73% Insiders
26.87% Mutual Funds
21.93% Other Institutional Investors
50.47% Public Companies and
Individual Investors
0R19 FAQ
What was Becton Dickinson And Company’s price range in the past 12 months?
Currently, no data Available
What is Becton Dickinson And Company’s market cap?
Currently, no data Available
When is Becton Dickinson And Company’s upcoming earnings report date?
Becton Dickinson And Company’s upcoming earnings report date is May 02, 2024 which is in 5 days.
How were Becton Dickinson And Company’s earnings last quarter?
Becton Dickinson And Company released its earnings results on Feb 01, 2024. The company reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.4 by $0.28.
Is Becton Dickinson And Company overvalued?
According to Wall Street analysts Becton Dickinson And Company’s price is currently Undervalued.
Does Becton Dickinson And Company pay dividends?
Becton Dickinson And Company pays a Quarterly dividend of $0.95 which represents an annual dividend yield of 1.59%. See more information on Becton Dickinson And Company dividends here
What is Becton Dickinson And Company’s EPS estimate?
Becton Dickinson And Company’s EPS estimate is $2.97.
How many shares outstanding does Becton Dickinson And Company have?
Currently, no data Available
What happened to Becton Dickinson And Company’s price movement after its last earnings report?
Becton Dickinson And Company reported an EPS of $2.68 in its last earnings report, beating expectations of $2.4. Following the earnings report the stock price went up 0.67%.
Which hedge fund is a major shareholder of Becton Dickinson And Company?
Among the largest hedge funds holding Becton Dickinson And Company’s share is Longview Partners (Guernsey) Ltd. It holds Becton Dickinson And Company’s shares valued at 524M.
---
Becton Dickinson Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$288.71 (24.78% Upside)
$288.71 (24.78% Upside)
Blogger Sentiment
Bullish
GB:0R19 Sentiment 87%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $67.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.32%
12-Months-Change
Fundamentals
Return on Equity
5.13%
Trailing 12-Months
Asset Growth
-1.61%
Trailing 12-Months
Company Description
Becton Dickinson And Company
Founded in 1897, Becton, Dickinson & Co. is a New Jersey-based medical technology company. The company develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional.
---
0R19 Company Deck
---
0R19 Earnings Call
Q1 2024
0:00 / 0:00
---
0R19 Revenue Breakdown
22.16% Medication Delivery Solutions
18.71% Integrated Diagnostic Solutions
15.38% Medication Management Solutions
11.51% Pharmaceutical Systems
32.24% Other
---
0R19 Stock 12 Months Forecast
Average Price Target
$288.71
▲(24.78% Upside)
Technical Analysis
Best Analysts Covering 0R19
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+5.42%
reiterated a buy rating 10 months ago
Copying Vijay Kumar's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +5.42% per trade.
---